Activin and Inhibin

BRD7586 is a cell-permeable small-molecule inhibitor of SpCas9. BRD7586 is the smallest known anti-CRISPR.In VitroBRD7586 specifically engages SpCas9 but not Cas12a in cells. BRD7586 (0-20 μM: 24 h) dose-dependently inhibits SpCas9 in the

BRD9500 is an orally active phosphodiesterases 3 ( PDE3 ) inhibitor with IC 50 s of 10 and 27 nM for PDE3A and PDE3B , respectively. Antitumor activityIn VitroBRD9500 is a DNMDP analog. DNMDP potently and selectively inhibits PDE3A and PDE3B and

BRD9500 is an orally active phosphodiesterases 3 ( PDE3 ) inhibitor with IC 50 s of 10 and 27 nM for PDE3A and PDE3B , respectively. Antitumor activityIn VitroBRD9500 is a DNMDP analog. DNMDP potently and selectively inhibits PDE3A and PDE3B and

BRD9500 is an orally active phosphodiesterases 3 ( PDE3 ) inhibitor with IC 50 s of 10 and 27 nM for PDE3A and PDE3B , respectively. Antitumor activityIn VitroBRD9500 is a DNMDP analog. DNMDP potently and selectively inhibits PDE3A and PDE3B and

BRD9500 is an orally active phosphodiesterases 3 ( PDE3 ) inhibitor with IC 50 s of 10 and 27 nM for PDE3A and PDE3B , respectively. Antitumor activityIn VitroBRD9500 is a DNMDP analog. DNMDP potently and selectively inhibits PDE3A and PDE3B and

BRD9500 is an orally active phosphodiesterases 3 ( PDE3 ) inhibitor with IC 50 s of 10 and 27 nM for PDE3A and PDE3B , respectively. Antitumor activityIn VitroBRD9500 is a DNMDP analog. DNMDP potently and selectively inhibits PDE3A and PDE3B and

Brensocatib (AZD7986) is an oral dipeptidyl peptidase 1 ( DPP1 ) inhibitor with pIC 50 s of 6.85, 7.6, 7.7, 7.8, and 7.8 in human, mouse, rat, dog and rabbit, respectivelyIn VitroResults from cell assay show that Brensocatib (AZD7986) is a

Brensocatib (AZD7986) is an oral dipeptidyl peptidase 1 ( DPP1 ) inhibitor with pIC 50 s of 6.85, 7.6, 7.7, 7.8, and 7.8 in human, mouse, rat, dog and rabbit, respectivelyIn VitroResults from cell assay show that Brensocatib (AZD7986) is a

Brensocatib (AZD7986) is an oral dipeptidyl peptidase 1 ( DPP1 ) inhibitor with pIC 50 s of 6.85, 7.6, 7.7, 7.8, and 7.8 in human, mouse, rat, dog and rabbit, respectivelyIn VitroResults from cell assay show that Brensocatib (AZD7986) is a

Brensocatib (AZD7986) is an oral dipeptidyl peptidase 1 ( DPP1 ) inhibitor with pIC 50 s of 6.85, 7.6, 7.7, 7.8, and 7.8 in human, mouse, rat, dog and rabbit, respectivelyIn VitroResults from cell assay show that Brensocatib (AZD7986) is a

Product Describtion:Brequinar (DUP785, NSC 368390) is an inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of ∼20 nM in vitro.

Product Describtion:Brequinar (DUP785, NSC 368390) is an inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of ∼20 nM in vitro.